HMT advised Ethos Partners on their investment in Bray Group, a long-established UK manufacturer of medical products.
Founded in 1857 and based in Farringdon, Oxfordshire, Bray began as a family business over a century ago. Today, it has grown into a leading manufacturer and supplier of medical products, specialising in caustics and pessaries. Bray operates through its three brands Avoca, Portia, and Bray Healthcare, serving approximately 400 customers across 35 international markets.
Ethos’ investment, supported by Triple Point, facilitates the buyout of existing shareholders and will support Bray and its management team on their journey toward its next phase of development. This includes a strategic plan aimed at broadening international reach and developing existing products.
HMT undertook financial due diligence on this transaction.
“The team at HMT provided great support on this transaction delivering high quality financial and commercial insight and analysis. They were efficient in getting the process going, worked in a flexible and communicative way, and were instrumental in getting the deal across the line.”
– Pascal Wittet, Partner – Ethos
“We are delighted to have advised Ethos on their investment in Bray Group. The business operates in a growing industry and with Ethos’ support, the business will be able to reach their ambitious growth plans. We look forward to working with them again in the future.”
– Paul Read
